Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes    » A1c    » Adolescents    » Awareness    » Cause    » Children    » Complications    » Control    » Costs    » Cure    » Diagnosis    » Drugs    » Elderly    » Gestational    » Hypoglycemia    » Impaired Fasting Glucose    » Impaired Glucose Tolerance    » Inflammation    » Insulin Resistance    » Insulin Sensitivity    » Men    » Metabolic Syndrome    » Minorities    » Obesity    » Organs    » Other Diseases    » Pancreas    » Pre-Diabetes    » Prevention    » Research    » Risk Factors    » Screening    » Statistics    » Stress    » Syndrome X    » Testing    » Treatments    » Type 1    » Type 2    » Warning Signs    » Women Body Care Children Complications Defeat Diabetes Foundation Drugs Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

About Diabetes » Drugs

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

Efficacy and Safety of Bydureon Versus Metformin, Pioglitazone, and Sitagliptin as Monotherapy Posted: Monday, February 06, 2012

In a once weekly injection of exenatide for Drug-Naive Patients with Type 2 Diabetes (DURATION-4) in a 26-week double-blind study they found that exenatide once weekly (EQW) was noninferior to metformin (MET) but not pioglitazone (PIO) and superior to sitagliptin (SITA) with regard to HbA1c reduction at 26 weeks.

Metformin May Help Protect Women against Pancreatic Cancer Posted: Sunday, February 05, 2012

A new study links the diabetes drug metformin to fewer cases of pancreatic cancer -- at least in women -- but finds other diabetes medications are associated with a higher risk of the disease.

FDA Approves BYDUREON™ -- The First Once-Weekly Treatment for Type 2 Diabetes Posted: Sunday, January 29, 2012

Once weekly Bydureon will be available in February at the approximate coast of $323 dollars a month which will include 4 injection syringes using 1 per week.

Intranasal Insulin Boosts Cognitive Function Posted: Saturday, January 28, 2012

Pooled data suggest that intranasal insulin may have a positive effect on cognition in both impaired and normal subjects.

For T2DM, the Quality of Guidelines on Oral Meds Varies Dramatically Posted: Saturday, January 07, 2012

According to the results of a systematic review, not all practice guidelines on oral medications for type 2 diabetes are consistent with available evidence, and guideline quality varies widely.

CDC: Hep B Vaccine Needed for Diabetic Adults Posted: Monday, January 02, 2012

Diabetic adults should be vaccinated against hepatitis B virus (HBV) as soon as possible after the diabetes diagnosis is made.

Diabetes Reversed with Investigational Weight Loss Drug Posted: Wednesday, December 28, 2011

Slightly more than a year of treatment with an investigational obesity drug that the FDA rejected for approval last year reversed type 2 diabetes in 15% of subjects.

Research Finds That Patients with Diabetes Should Take More Vitamin B12 Daily Posted: Monday, December 26, 2011

People who have type 2 diabetes and are taking metformin should take more than the recommended daily allowance of vitamin B12.

Omega-3 Fatty Acids Staves Off CV Events in High-risk Patients with Diabetes Posted: Saturday, November 26, 2011

New data suggests that low-dose supplementation with omega-3 fatty acids may protect patients with diabetes and a history of myocardial infarction from ventricular arrhythmia-related events.

Omega-3 Use Shows Diabetes Benefits Posted: Monday, November 07, 2011

A new study has found that omega-3 fatty acids, better known as fish oil, may help to protect against chronic inflammation and insulin resistance.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.